CUC study materials
CUC study resources

Recurrent UTI Versus Overactive Bladder in an Older Woman

CUC · Put your knowledge to work in context.

All case studies

Recurrent UTI Versus Overactive Bladder in an Older Woman

A 71-year-old woman is referred for 'recurrent UTIs' - four culture-positive episodes in 12 months, each treated with 3–5 days of antibiotics. Between episodes she reports urgency, frequency (every 1–2 hours), and nocturia twice nightly, with occasional urge leakage. She also has a 3-day history of dysuria and cloudy urine now; a dipstick is positive for leukocyte esterase and nitrite. She is postmenopausal, has type 2 diabetes (A1c 7.4%), and takes an SGLT2 inhibitor. She has tried cranberry capsules without benefit. She is frustrated and asks for 'a daily antibiotic forever.'

1. How do you distinguish true recurrent UTI from OAB with a positive dipstick, and what testing is warranted now?

Read the worked answer

The clinical trap is treating sterile pyuria or asymptomatic bacteriuria as UTI. Her chronic urgency/frequency/nocturia is more consistent with OAB, while the current dysuria and cloudy urine with a positive dipstick suggests an acute episode that should be cultured before treatment.

Steps:

  • Urinalysis with microscopy and a urine culture with susceptibilities on the current symptomatic episode. Dipstick alone is not sufficient; nitrite/leukocyte esterase can be positive with asymptomatic bacteriuria, which is common in older women and in diabetes.
  • Review prior cultures: were the 'recurrent UTIs' actually culture-positive with the same organism, or were some treated on dipstick alone? True recurrent UTI is defined by culture-documented episodes.
  • Do not treat asymptomatic bacteriuria between episodes; it drives resistance and does not reduce symptomatic recurrence.
  • Consider post-void residual to rule out incomplete emptying, and a pelvic exam for prolapse or atrophy contributing to urgency.
  • Note the SGLT2 inhibitor: glycosuria increases UTI and genital mycotic infection risk; discuss with her primary care team.

If cultures confirm recurrent UTI, then prophylaxis strategies (behavioral, vaginal estrogen, and only then antibiotic prophylaxis) are appropriate.

2. Assuming culture confirms E. coli, outline a stepwise non-antibiotic-first prevention plan and when you would escalate.

Read the worked answer

Non-antibiotic measures first, with realistic expectations:

  • Topical vaginal estrogen if atrophic - this is one of the best-evidenced interventions for recurrent UTI in postmenopausal women, restoring Lactobacillus and lowering pH.
  • Hydration and voiding habits; avoid bladder irritants if they worsen urgency.
  • Methenamine hippurate is a reasonable option for prophylaxis in women with recurrent UTI and normal renal function; it is not a treatment for acute infection.
  • D-mannose has modest evidence; cranberry has limited benefit and she has already tried it.
  • Address the SGLT2 inhibitor with her diabetes team - glycosuria is a modifiable risk.

Escalation:

  • If she has ≥2 culture-proven episodes in 6 months or ≥3 in 12 months despite the above, offer continuous or postcoital antibiotic prophylaxis (e.g., low-dose nightly or postcoital dosing) with culture-guided choice and periodic reassessment.
  • Methenamine can be used instead of antibiotics in selected patients.
  • Reassess every 3–6 months; avoid indefinite prophylaxis without review.

Also treat the OAB component separately (behavioral therapy, bladder training, and if needed an antimuscarinic or beta-3 agonist) - otherwise her urgency symptoms will keep being mislabeled as UTI.

3. What would make you suspect a complicated or upper-tract problem rather than uncomplicated recurrent cystitis?

Read the worked answer

Red flags that change the workup:

  • Fever, flank pain, rigors, or systemic symptoms - suggests pyelonephritis or obstruction.
  • Hematuria (gross or persistent microscopic) - warrants cystoscopy and upper-tract imaging.
  • Stones, prior urologic surgery, indwelling catheter, or neurogenic bladder - complicated UTI.
  • Diabetes with poor control, immunosuppression, or renal impairment.
  • Failure to respond to appropriate culture-directed antibiotics, or a rapid relapse suggesting a source such as a stone or fistula.
  • Recurrent infection with unusual organisms (e.g., Proteus, Klebsiella, Enterococcus) or a change in organism pattern.

In her case, the diabetes and SGLT2 inhibitor raise the index of suspicion for emphysematous or complicated infection if she becomes systemically unwell, and glycosuria should prompt counseling. If she has any of the above, obtain renal ultrasound or CT and consider urology referral rather than continuing oral prophylaxis.